Submitted:
16 May 2024
Posted:
17 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Ethics
2.2. Sporothrix Strains
2.3. Macro and Micro-Morphological Identification
2.4. Molecular Identification
2.5. Antifungal Susceptibility
2.6. Fungi Thermotolerance
2.7. Melanin Production
2.8. Urease Production
2.9. Biofilm Formation
2.10. Statistical Analysis
2.11. Phylogenetic Tree
3. Results
3.1. Macro and Micro-Morphological Identification
3.2. Molecular Identification
3.3. Antifungal Susceptibility
3.4. Thermotolerance
3.5. Melanin Production
3.6. Urease Production
3.7. Biofilm Production
3.8. Phylogenetic Tree
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Fernandes B, Caligiorne RB, Coutinho DM, Gomes RR, Rocha-Silva F, Machado AS, Santrer EFR, Assunção CB, Guimarães CF, Laborne MS, Nunes MB, Vicente VA, de Hoog S. A case of disseminated sporotrichosis caused by Sporothrix brasiliensis. Med. Mycol. Case Rep. 2018; 21:34–36. [CrossRef]
- Gómez-Gaviria M, Martínez-Álvarez JA, Mora-Montes HE. Current Progress in Sporothrix brasiliensis Basic Aspects. J Fungi (Basel). 2023; 9(5):533. [CrossRef]
- Rubio G, Sánchez G, Porras L Alvarado Z. Sporotrichosis: prevalence, clinical and epidemiological features in a reference center in Colombia. Rev. Iberoam Micologia. 2010;27(2):75–9. :. [CrossRef]
- Bonifaz A, Vázquez-González D. Diagnosis and treatment of lymphocutaneous sporotrichosis: What are the options? Curr. Fungal Infect. Rep. 2013; 7:252–259. [CrossRef]
- Gremião IDF, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA. Feline sporotrichosis: epidemiological and clinical aspects. Med. Mycol. 2015;53(1):15–21. [CrossRef]
- Macêdo-Sales PA, Souto SRLS, Destefani CA, Lucena RP, Machado RLD, Pinto MR, Rodrigues AM, Lopes-Bezerra LM, Rocha EMS, Baptista ARS. Domestic feline contribution in the transmission of Sporothrix in Rio de Janeiro State, Brazil: A comparison between infected and non-infected populations. BMC Vet. Res.2018; 14:1–10. [CrossRef]
- Rodrigues A, Hoog G, Camargo Z. Genotyping species of the Sporothrix schenckii complex by PCR-RFLP of calmodulin. Diagn Microbiol Infect Dis. 2014;78(4):383-7. [CrossRef]
- de Carvalho JA, Beale MA, Hagen F, Fisher MC, Kano R, Bonifaz A, Toriello C, Negroni R, Rego RSM, Gremião IDF, Pereira SA, de Camargo ZP, Rodrigues AM. Trends in the molecular epidemiology and population genetics of emerging Sporothrix species. Stud Mycol. 2021;100 (100129):1-31. [CrossRef]
- Moncrieff IA, Capilla J, Fernández AM, Fariñas F, Mayayo E. Diferencias en la patogenicidad del complejo de especies Sporothrix en un modelo animal Artículo original. Patol. Rev. Latinoam. 2010; 48(2): 82–87.
- Teixeira MM, de Almeida LG, Kubitschek-Barreira P, Alves FL, Kioshima ÉS, Abadio AK, Fernandes L, Derengowski LS, Ferreira KS, Souza RC, Ruiz JC, de Andrade NC, Paes HC, Nicola AM, Albuquerque P, Gerber AL, Martins VP, Peconick LD, Neto AV, Chaucanez CB, Silva PA, Cunha OL, de Oliveira FF, dos Santos TC, Barros AL, Soares MA, de Oliveira LM, Marini MM, Villalobos-Duno H, Cunha MM, de Hoog S, da Silveira JF, Henrissat B, Niño-Vega GA, Cisalpino PS, Mora-Montes HM, Almeida SR, Stajich JE, Lopes-Bezerra LM, Vasconcelos AT, Felipe MS. Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis. BMC Genomics. 2014; 15:943. [CrossRef]
- Rodrigues AM, Della Terra PP, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020;185(5):813–842. [CrossRef]
- Rossow JÁ, Queiroz-Telles F, Caceres DH, Beer KD, Jackson BR, Pereira JG, Gremião IDF, Pereira SA. A one health approach to combatting Sporothrix brasiliensis: Narrative review of an Emerging Zoonotic Fungal Pathogen in South America. J Fungi (Basel). 2020;6(4):247. [CrossRef]
- Aung AK, Teh BM, McGrath C, Thompson PJ. Pulmonary sporotrichosis: Case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. Med. Mycol.2013;51(5):534–544. [CrossRef]
- Almeida-Paes R, de Oliveira MM, Freitas DF, do Valle AC, Zancop-Oliveira RM, Gutierrez-Galhardo MC. Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations. PLoS Negl. Trop. Dis. 2014; 8(9): e3094. [CrossRef]
- Belda W, Domingues Passero LF, Stradioto Casolato AT. Lymphocutaneous Sporotrichosis. Refractory to First-Line Treatment. Case Rep. Dermatol. Med. 2021:9453701. [CrossRef]
- Almeida-Paes R, De Oliveira LC, Oliveira MME, Gutierrez-Galhardo MC, Nosanchuk JD, Zancopé-Oliveira RM. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res. Int. 2015; 2015:212308. [CrossRef]
- Arrillaga-Moncrieff I, Capilla J, Mayayo E, Marimon R, Mariné M, Gené J, Cano J, Guarro J. Different virulence levels of the species of Sporothrix in a murine model. Clin. Microbiol. Infect. 2009;15(7):651–655. [CrossRef]
- Rabello VBS, Almeida MA, Bernardes-Engemann AR, Almeida-Paes R, de Macedo PM, Zancopé-Oliveira RM. The Historical Burden of Sporotrichosis in Brazil: a Systematic Review of Cases Reported from 1907 to 2020. Braz J Microbiol. 2022;53(1):231–244. [CrossRef]
- Sidrim JJC, Rocha MFG. Micologia médica à luz de autores contemporâneos. Ed Guanabara Koogan S.A. Rio de Janeiro, Brasil. 2004; 396pp.
- Fernandes B, Santrer EFR, Figueiredo SM, Rocha-Silva F, Assunção CB, Abreu AG, Santiago IF, Johann S, Caligiorne RB. Sporotrichosis: In silico design of new molecular markers for the Sporothrix genus. Rev Soc Bras Med Trop. 2023; 56(e0217-2022):1-4. [CrossRef]
- Rodrigues AM, de Hoog GS, de Camargo ZP. Genotyping species of the Sporothrix schenckii complex by PCR-RFLP of calmodulin. Diagn Microbiol Infect Dis. 2014;78(4):383–7.
- CLSI. Reference method for broth dilution. M27-A3 Ref. Method Broth Diluition Antifung. Susceptibility Test. Yeasts; Approv. Stand. - Third Ed. 28, (2008).
- Pierce, CG. , Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96 well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9): 1494–1500. [CrossRef]
- Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform, Nucleic Acids Res. 2002;30(14):3059–3066. [CrossRef]
- Sela I, Ashkenazy H, Katoh K, Pupko T. GUIDANCE 2: accurate detection of unreliable alignment regions accounting for the uncertainty of multiple parameters. Nucleic Acids Res, 2015; 43(W1): W7-W14. [CrossRef]
- Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics, 2014;30(9):1312-1313. [CrossRef]
- Letunic I, Bork P. Interactive Tree of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2007; 23(1):127-8. [CrossRef]
- Gremião IDF, Miranda LHM, Reis EG, Rodrigues AM, Pereira SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017; 13(1):e1006077. [CrossRef]
- Colombo SA, Bicalho GC, de Oliveira CSF, Soares DFM, Salvato LA, Keller KM, Bastos CV, Morais MHF, Rodrigues AM, Cunha JLR, de Azevedo MI. Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease. Mycoses. 2023; 66: 911-922. [CrossRef]
- Lecca LO, Paiva MT, de Oliveira CSF, Morais MHF, de Azevedo MI, Bastos CV, Keller KM, Ecco R, Alves MRS, Pais GCT, Salvato LA, Xaulim GMD, Barbosa DS, Brandão ST, Soares DFM. Associated factors and spatial patterns of the epidemic sporotrichosis in a high density human populated area: A cross-sectional study from 2016 to 2018. Prev. Vet. Med. 2020; 176:104939. [CrossRef]
- Espinel-Ingroff A, Abreu DBR, Almeida-Paes R, Brilhante RSN, Chakrabarti A, Chowdhary A, Hagen F, Córdoba S, Gonzalez GM, Govender NP, Guarro J, Johnson EM, Kidd SE, Pereira SA, Rodrigues AM, Rozental S, Szeszs MW, Ballesté-Alaniz R, Bonifaz A, Bonfietti LX, Borba-Santos LP. Capilla J. Colombo AL, Dolande M, Isla MG, Melhem MSC, Mesa-Arango AC, Oliveira MME, Panizo MM, Camargo ZP, Zancope-Oliveira RM, Meis JF, Turnidge J. Multicenter, International Study of MIC / MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods. Antimicrob. Agents Chemother. 2017; 61(10):1–8. [CrossRef]
- Almeida-Paes R, Brito-Santos F, Figueiredo-Carvalho MHG, Machado ACS, Oliveira MME, Pereira SA, Gutierrez-Galhardo MC, Zancopé-Oliveira RM. Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis. Mem. Inst. Oswaldo Cruz. 2017; 112(2): 376–381. [CrossRef]
- Lloret A, Hartmann K, Pennisi MG, Ferrer L, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hosie MJ, Lutz H, Marsilio F, Möstl K, Radford AD, Thiry E, Truyen U, Horzinek MC. Sporotrichosis in cats: ABCD guidelines on prevention and management. J. Feline Med. Surg. 2013; 15(7): 619–623. [CrossRef]
- He D, Zhang X, Gao S, You H, Zhao Y, Wang L. Transcriptome Analysis of Dimorphic Fungus Sporothrix schenckii Exposed to Temperature Stress. Int. Microbiol. 2021; 24(1): 25–35. [CrossRef]
- Hogan LH, Klein BS, Levitz SM. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 1996; 9(4):469–488. [CrossRef]
- Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 2006;50(11):3519–3528. [CrossRef]
- Ghosh A, Maity PK, Hemashettar BM, Sharma VK, Chakrabarti A. Physiological characters of Sporothrix schenckii isolates. Mycoses. 2002; 45(11-12): 449–454. [CrossRef]
- Mendoza M, Alvarado P, Díaz-de-Torres E, Lucena L, De Albornoz MC. Comportamiento fisiológico y de sensibilidad in vitro de aislamientos de Sporothrix schenckii mantenidos 18 años por dos métodos de preservación. Rev. Iberoam. Micol. 2005; 22(3): 151–156. [CrossRef]
- Madrid IM, Xavier MO, Mattei AS, Fernandes CG, Guim TN, Santin R, Schuch LFD, Nobre MO, Araújo-Meireles MC. Role of melanin in the pathogenesis of cutaneous sporotrichosis. Microbes Infect. 2010; 12(2): 162–165. [CrossRef]
- García-Carnero LC, Martínez-Álvarez JA. Virulence Factors of Sporothrix schenckii. J. Fungi. 2022; 8(3): 318. [CrossRef]
- Morris-Jones R, Youngchim S, Gomez BL, Aisen P, Hay RJ, Nosanchuk JD, Casadevall A, Hamilton AJ. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect. Immun. 2003; 71(7): 4026–4033. [CrossRef]
- Van-Duin D, Casadevall A, Nosanchuk JD. Reduces Their Susceptibilities to Amphotericin B and Caspofungin. Antimicrob. Agents Chemother 2002; 46(11): 3394–3400. [CrossRef]
- Jacobson, ES. Pathogenic roles for fungal melanins. Clin. Microbiol. Rev. 2000; 13(4): 708–717. [CrossRef]
- Mirbod-Donovan F, Schaller R, Hung CY, Xue J, Reichard U, Cole GT. Urease produced by Coccidioides posadasii contributes to the virulence of this respiratory pathogen. Infect. Immun. 2006;74(1):504–515. [CrossRef]
- Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol. Rev. 1995; 59(3): 451–480. [CrossRef]
- Dos Santos GMP, Borba-Santos LP, Vila T, Gremião IDF, Pereira SA, De Souza W, Rozental SI. Sporothrix spp. Biofilms Impact in the Zoonotic Transmission Route: Feline Claws Associated Biofilms, Itraconazole Tolerance, and Potential Repurposing for Miltefosine. Pathogens. 2022; 11(2): 206. [CrossRef]
- Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D’Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: Development, architecture, and antifungal resistance. Antimicrob. Agents Chemother. 2006; 50(10):3 269–3276. [CrossRef]
- Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog. 2012;8(4):1–4. [CrossRef]
- Mitchell KF, Zarnowski R, Andes DR. Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions. PLoS Pathog. 2016; 12(9): 1–6. [CrossRef]
- Brilhante RSN, Fernandes MR, Pereira VS, Costa AC, Oliveira JS, de Aguiar L, Rodrigues AM, de Camargo ZP, Pereira-Neto WA, Sidrim JJC, Rocha MFG. Biofilm formation on cat claws by Sporothrix species: An ex vivo model. Microb. Pathog. 2021; 150:104670. [CrossRef]
- Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 2011; 9(2): 109–118. [CrossRef]
- Boltz JP, Smets BF, Rittmann BE, Van Loosdrecht MCM, Morgenroth E, Daigger GT. From biofilm ecology to reactors: a focused review. Water Sci. Technol. 2017; 75(7-8): 1753–1760. [CrossRef]
- Cavalheiro M, Teixeira MC. Candida Biofilms: Threats, challenges, and promising strategies. Front. Med. Front Med (Lausanne). 2018; 5:28. [CrossRef]
- Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol. 2012; 2012:528521. [CrossRef]
- Garcia LGS, de Melo-Guedes GM, Fonseca XMQC, Pereira-Neto WA, Castelo-Branco DSCM, Sidrim JJC, de Aguiar-Cordeiro R, Rocha MFG, Vieira RS, Brilhante RSN. Antifungal activity of different molecular weight chitosans against planktonic cells and biofilm of Sporothrix brasiliensis. Int. J. Biol. Macromol. 2020;143:341–348. [CrossRef]
- Sánchez-Herrera R, Flores-Villavicencio LL, Pichardo-Molina JL, Castruita-Domínguez JP, Aparicio-Fernández X, López MS, Villagómez-Castro JC. Analysis of biofilm formation by Sporothrix schenckii. Med. Mycol. 2021; 59(1): 31–40.





| Humans (n=27) |
Felines (n=21) |
|||
|---|---|---|---|---|
| n (%) | n (%) | |||
| Antifungal susceptibility - Minimum inhibitory concentration (MIC) | ||||
| Amphotericin B | 0.000a* | |||
| 0.125 µg/mL | 3 (11.11) | 0 (0.00) | ||
| 0.25 µg/mL | 10 (37.04) | 0 (0.00) | ||
| 0.5 µg/mL | 8 (29.63) | 2 (9.52) | ||
| 1.0 µg/mL | 6 (22.22) | 19 (90.48) | ||
| Itraconazole | 0.115a | |||
| 0.125 µg/mL | 1 (3.70) | 0 (0.00) | ||
| 0.25 µg/mL | 4 (14.81) | 0 (0.00) | ||
| 0.5 µg/Ml | 22 (81.48) | 21 (100.0) | ||
| Thermotolerance | ||||
| 41°C | 0.000a* | |||
| + | 13 (50.00) | 0 (0.00) | ||
| ++ | 13 (50.00) | 13 (61.90) | ||
| +++ | 0 (0.00) | 8 (38.10) | ||
| 45°C | 0.000b* | |||
| + | 17 (80.95) | 6 (28.57) | ||
| ++ | 4 (19.05) | 15 (71.43) | ||
| 50°C | --- | |||
| + | 11 (100.0) | 15 (100.0) | ||
| Melanin production | ||||
| + | 10 (37.4) | 6 (28.57) | 0.651b | |
| ++ | 7 (25.93) | 8 (38.10) | ||
| +++ | 10 (37.04) | 7 (33.33) | ||
| Urease production | ||||
| + | 6 (22.22) | 5 (23.81) | 0.765b | |
| ++ | 9 (33.33) | 5 (23.81) | ||
| +++ | 12 (44.44) | 11 (52.38) | ||
| Biofilm production | ||||
| + | 8 (29.63) | 9 (42.86) | 0.081b | |
| ++ | 7 (25.93) | 9 (42.86) | ||
| +++ | 12 (44.44) | 3 (14.29) | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).